Diabetes Clinical Trials in Houston

Showing 241-260 of 277 trials

Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy

NCT00476931

The purpose of the study is to study the clinical effects of the investigational drug, SB-509 versus placebo in patients with diabetic neuropathy.

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2Diabetic Polyneuropathy

Sangamo Therapeutics91 participantsStarted May 2007

La Jolla, California, United States • Lakewood, California, United States • Lomita, California, United States +17 more locations

COMPLETED< 1 mile

Follow-Up Study for Exubera

NCT00734591

In studies of Exubera in persons with diabetes, lung cancer occurred in a few more people who were taking Exubera than in people who were taking other diabetes medicines. All subjects diagnosed with lung cancer had a history of smoking and the number of lung cancer cases observed fell within the expected range based on population-based data. There is currently not enough information to determine if any of the observed lung cancer cases were related to Exubera use, therefore, the study is being conducted to further investigate whether Exubera use makes the appearance of lung cancer more likely.

Diabetes Mellitus

Pfizer7,439 participantsStarted Aug 2008

Bay Minette, Alabama, United States • Graysville, Alabama, United States • Pell City, Alabama, United States +318 more locations

Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy

Follow-Up Study for Exubera

Diabetes Trials in Other Cities

WelChol® and Insulin in Treating Patients With Type 2 Diabetes

Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin Alone

A Comparison Of Study Drug Blood Levels After One Dose Of GSK189075 In Subjects With Normal And Reduced Kidney Function

Safety Study of BMS-903452 in Healthy Subjects (Panel 1-7) & Relative Bioavailability of the Crystalline and Amorphous Forms of BMS-903452 [Panels 4, 6, 11 & 12(Part A)], and Subjects With Type 2 Diabetes Mellitus (Part B)

Long-Term Safety Study of Inhaled Insulin: An Up to Four-Year Extension of Therapy in Subjects With Type 1 or Type 2 Diabetes Mellitus

Study of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes Mellitus

Study of the Glycemic Effects of Nebivolol Compared With Metoprolol and HCTZ in Diabetic Hypertensive Patients

Treatment Effect of Saxagliptin Compared With Placebo in Patients With Type 2 Diabetes and Renal Impairment

Evaluate the Safety and Tolerability of INCB019602 When Administered With Metformin in Patients With Type 2 Diabetes

Mechanisms of Glucose Lowering Effect of Colesevelam HCl

The TANTALUS® II System for the Treatment of Type 2 Diabetes: A Randomized Study

Mechanism of Action and Efficacy of Muraglitazar in Type 2 Diabetes

18 Week Study Evaluating Safety and Efficacy of Olmesartan, Amlodipine, and Hydrochlorothiazide, in Type 2 Diabetics

Lantus Versus NPH: Comparison in Insulin Naive People Not Adequately Controlled With at Least One Oral Anti Diabetics (OAD) Treatment

A Study for Patients With Type 2 Diabetes Mellitus

DPBRN Blood Sugar Testing in Dental Patients

GALLANT 6 Tesaglitazar vs. Pioglitazone

Testing the Developmental Origins Hypothesis

Other Conditions in Houston